'Ozempic feet' is an informal term that has emerged in patient communities and social media to describe various foot-related symptoms some individuals report whilst taking Ozempic (semaglutide)
Insulin regulates lipolysis and fat mass by upregulating growth/differentiation factor 3 in adipose tissue macrophages
Compare this to semaglutide, where the dosing protocol involves gradual escalation over 16 to 20 weeks
Science 295:10111011 Pevec D, Novinscak T, Brcic L, Sipos K, Jukic I, Staresinic M, Mise S, Brcic I, Kolenc D, Klicek R, Banic T (2010) Impact of pentadecapeptide BPC 157 on muscle healing impaired by systemic corticosteroid application
Cell-and tissue-specific epigenetic changes associated with chronic inflammation in insulin resistance and type 2 diabetes mellitus
No trial has followed patients long enough after stopping to answer this